Oral hypoglycaemic drugs and gastrointestinal symptoms in diabetes mellitus.
about
Upper and/or lower gastrointestinal adverse events with glucagon-like peptide-1 receptor agonists: Incidence and consequences.Medical management of fecal incontinence in challenging populations: a review.Worms need microbes too: microbiota, health and aging in Caenorhabditis elegansGastric emptying in diabetes: clinical significance and treatment.Gastrointestinal adverse events of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a systematic review and network meta-analysis.Diabetic gastropathy and prokinetics.Impact of GLP-1 receptor agonists on major gastrointestinal disorders for type 2 diabetes mellitus: a mixed treatment comparison meta-analysisConstipation, hard stools, fecal urgency, and incomplete evacuation, but not diarrhea is associated with diabetes and its related factorsPharmacokinetic and pharmacodynamic interactions between metformin and a novel dipeptidyl peptidase-4 inhibitor, evogliptin, in healthy subjects.Metformin retards aging in C. elegans by altering microbial folate and methionine metabolism.The Association Between Fasting C-peptide and Gastrointestinal Symptoms of Gastroparesis in Type 2 Diabetic Patients.Evaluation of Potentially Drug-Related Patient-Reported Common Symptoms Assessed During Clinical Medication Reviews: A Cross-Sectional Observational Study.A review of methods used in assessing non-serious adverse drug events in observational studies among type 2 diabetes mellitus patients.Comparing adverse event rates of oral blood glucose-lowering drugs reported by patients and healthcare providers: a post-hoc analysis of observational studies published between 1999 and 2011.Drug-induced gastrointestinal disorders.Measuring experiences and outcomes of patient safety in primary care: a systematic review of available instruments.Diabetes-related dysfunction of the small intestine and the colon: focus on motility.New insights into the anti-diabetic actions of metformin: from the liver to the gut.Symptoms of infectious diseases in travelers with diabetes mellitus: a prospective study with matched controls.Symptom clustering in subjects with and without diabetes mellitus: a population-based study of 15,000 Australian adults.Do risk factors for lactic acidosis influence dosing of metformin?CCR2 upregulation in DRG neurons plays a crucial role in gastric hyperalgesia associated with diabetic gastropathy.Gut symptoms in diabetics correlate with components of the rectoanal inhibitory reflex, but not with pudendal nerve motor latencies or systemic autonomic neuropathy.
P2860
Q33626001-A64B6B87-2454-4534-84C2-732CD9E6B81EQ34239563-15383A9E-DD7F-4AC6-9803-6CD36A6F8840Q34361733-2554AD67-0DCC-4D96-B7F4-0B2D9AC5DB5AQ34579697-4FBDFB48-271E-401A-B618-C8C472AE33ABQ34915090-AA1FEAF0-BE6D-4D48-BE05-7022B3E8828FQ35068007-EF7F95C7-0A44-49A0-B763-4819E8FF0666Q36520655-76456912-26D5-4DC2-8A56-96B725C33E85Q36682652-FDBEBE9E-15B1-42B9-8BC4-7585075E8CA2Q37179450-D231DFF0-ECA1-4985-9CCF-DC61D8E6C953Q37503122-683E03E9-9C64-474F-AE8A-439FCB4B1C34Q37740023-205E2A8C-6091-4D50-9FB4-8790EF9EEA28Q37742262-813F6B64-0C13-4565-A5B0-6903FC934190Q37940541-BE3A7702-175D-4631-B3BA-B1663D567969Q37955225-85CECDB1-980B-45C7-A5DF-A246E443CFCDQ38221321-4F4AEA2C-D518-4238-864C-2C89E477ED8FQ38246371-AFF00EF8-7CCD-49A5-9B03-E60DBF909F2AQ38587718-17ABE89E-976E-4A3E-90BF-CD2C1B8FB199Q39041261-40EF2625-1091-4B89-BCD4-3C6AE652A100Q43893476-00D9B561-9EB7-4EAC-95EE-5D524AC73DE4Q44318833-1FC3AA9C-584C-44F1-B262-5B61D1EED0EEQ45105247-3CC4DEB4-C37E-42D8-95BF-F79EA7948F26Q48187127-9DEB950A-4AD7-49F9-AE35-45526CF55D6DQ53582034-792F1E44-75E5-4DA0-B59E-E94AF48A2FAE
P2860
Oral hypoglycaemic drugs and gastrointestinal symptoms in diabetes mellitus.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Oral hypoglycaemic drugs and gastrointestinal symptoms in diabetes mellitus.
@ast
Oral hypoglycaemic drugs and gastrointestinal symptoms in diabetes mellitus.
@en
type
label
Oral hypoglycaemic drugs and gastrointestinal symptoms in diabetes mellitus.
@ast
Oral hypoglycaemic drugs and gastrointestinal symptoms in diabetes mellitus.
@en
prefLabel
Oral hypoglycaemic drugs and gastrointestinal symptoms in diabetes mellitus.
@ast
Oral hypoglycaemic drugs and gastrointestinal symptoms in diabetes mellitus.
@en
P2093
P2860
P1476
Oral hypoglycaemic drugs and gastrointestinal symptoms in diabetes mellitus
@en
P2093
P2860
P304
P356
10.1046/J.1365-2036.2001.00896.X
P407
P577
2001-01-01T00:00:00Z